Trademarkia Logo

Australia

AU$
RULOYUS
Protected: Renewal due

Last updated on 7 Sept 2023

Owner Info

Celgene Corporation

86 Morris Avenue Summit,

NJ 07901, UNITED STATES OF AMERICA

Serial Number

1722313 filed on 3 Aug 2015

Correspondent

KIRKPATRICK, SA/NV

Avenue Wolfers 32,

B-1310 La Hulpe,

BELGIUM

RULOYUS

Classification Information


Class [005]
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, bl Read More

Mark Details


Serial Number

1722313

Registered On

3 Aug 2015

Renewal On

3 Aug 2025

Mark Type

WORD

Priority Claim (Convention Details)


Date

13 Jul 2015

Mark Type

US

Legal History


Show more

Status DateAction Taken
7th Sept 2023Amendment to International Registration Contact Requested
6th May 2021Amendment to International Registration Contact Requested
25th Feb 2016IP Right Registration Published
18th Feb 2016Application Status
18th Feb 2016Register Trade Mark
10th Dec 2015IP Right Acceptance Published
27th Nov 2015Amend Status from Awaiting Advertisement
5th Nov 2015Application Accepted correspondence sent
5th Nov 2015Clear Examination report approved
5th Nov 2015User Created Notice correspondence sent